Solventum CORP 10-Q quarterly reports

Solventum Corporation's Q2 2026 Form 10-Q filing details stable revenue growth, strategic portfolio optimization, and ongoing cost-saving programs, alongside significant legal provisions and restructuring charges.

Solventum reports Q1 2026 net income of $13 million, reflecting ongoing restructuring costs and the impact of the Purification and Filtration business divestiture.

Solventum Corporation reports a significant increase in net income for Q3 2025, driven by a $1.5 billion gain from the sale of its Purification and Filtration business, alongside strategic debt reduction and a new multi-year cost savings program.

Solventum Corporation reported increased net sales for Q2 2025 but a significant decline in operating income and net income for the first six months, alongside an update on its Purification and Filtration business divestiture.

Solventum Corporation reports its Q1 2025 financial results, including a definitive agreement to sell its Purification and Filtration business to Thermo Fisher Scientific Inc.

Solventum Corporation's third quarter results show a slight increase in net sales but a decrease in operating income compared to the same period last year, following its spin-off from 3M.

Solventum Corporation's first quarterly report as an independent entity shows a slight increase in sales but a decrease in profitability compared to the same period last year.

Solventum Corporation, recently spun off from 3M, released its first quarterly report as an independent entity, showing a slight increase in net sales but a decrease in net income compared to the same period last year.